- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06286618
Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians
December 3, 2024 updated by: University of Southern Mississippi
Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians
The objective for the study is to implement a pilot study to establish essential components to address diet quality in healthcare settings and examine what value an integrated service model delivery has for the primary prevention of cardiometabolic diseases with an initial focus on dietary behaviors.
This objective will be met by 1: Utilizing a multiphase optimization study design to select and optimize essential components to address diet behaviors and 2: Comparing an integrated and referral-based delivery model for healthcare-based strategies that address structural and psychosocial barriers to a healthy diet for racial/ethnic minority, marginalized and disadvantaged background young to middle aged adult populations in Mississippi.
Study Overview
Status
Completed
Conditions
Detailed Description
The study is designed based on the multiphase optimization strategy (MOST), which includes three phases to prepare or screen, optimize, and evaluate multiple components of an intervention.
During first optimization phase, study team will conduct essential component selection by pilot testing three common strategies used in healthcare settings to deliver structural and psychosocial interventions that address diet behaviors.
The second optimization phase will include pilot testing to examine the optimization of delivery mode for the essential components identified in first phase.
In each phase, participants between 25 to 50 years of age who are at risk for CVD-related premature mortality will be recruited to complete a 3-month intervention in a community based clinical setting in Mississippi.
The proposed project will provide foundational knowledge for components and delivery models that are the most essential and cost-effective to improve dietary behaviors among racial/ethnic minority and disadvantaged background populations in Mississippi.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39406-0001
- The University of Southern Mississippi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 25 to 50 years of age
- cardiovascular disease-related premature mortality risk (people living with HIV/AIDS or diagnosed with or familial risk for diabetes, hypertension, obesity, or Metabolic syndrome)
- internet access
- Jackson (Mississippi) metropolitan statistical area residency
Exclusion Criteria:
- cancer with active treatment
- chronic obstructive pulmonary disorder, emphysema, cystic fibrosis or any other major lung disease
- liver or kidney dysfunction, end-stage renal disease, active hepatitis,
- celiac disease, colitis, or other gastrointestinal disorders
- current pregnancy or within six months postpartum at baseline
- heavy drinking
- unintentional weight loss of more than 5% of body weight within the past six months
- recent (in the past 6 months) heart attack, stroke or other major heart surgery or event
- eating disorders (anorexia or bulimia nervosa)
- currently being treated for a fungus, bacteria, viral, or other infection due to weak immune system
- Insulin dependent diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Psychosocial or Structural Intervention
During optimization 1 phase, participants are assigned to two groups: Psychosocial or Structural Intervention.
One group will receive psychosocial support for diet only and the other will receive structural support for diet only.
Each group will have three modalities.
|
Psychosocial intervention is an intensive behavioral therapy intervention to address dietary behaviors.
Each intervention session is a one-on-one interaction that focuses on setting individualized dietary goals and following up on them and is delivered by trained personnel.
Sessions are delivered in 3 modalities which include face-to-face, phone call, and telehealth delivery.
Each participant is randomly assigned to receive 4 weeks of each modality in one of the following orders: 1) Face-to-face; Telehealth; Phone Call 2) Telehealth; Phone Call; Face-to-face 3) Phone call; Face-to-face; Telehealth.
The structural intervention is designed to supplement the diet with food resources via three modalities: voucher-based or F/V prescription, home meal delivery, or food bank box program.
The voucher-based model includes a weekly $50 gift card with a prescription for having to eat more fruits and vegetables.
The home meal delivery model includes a meal subscription that supplements the diet with two meals for two people each week (four total servings worth $65 including shipping).
The food bank box program consists of participants picking up a box of food weekly from a food pantry located in the outpatient clinic.
Each participant is randomly assigned to receive 4 weeks of each modality in one of the following orders: 1) Voucher; Meal Delivery; Food Box 2) Meal Delivery; Food Box; Voucher 3) Food Box; Voucher; Meal Delivery.
|
|
Experimental: Combined Psychosocial and Structural Intervention
The optimization 2 phase will be used to test a combined psychosocial and structural intervention, based on the most feasible selections from optimization 1 phase.During optimization 2 phase, participants will be assigned to two groups.
One group will receive referral based delivery model for a combined psychosocial and structural intervention and the other group will receive an integrated delivery model for a combined psychosocial and structural intervention.
|
Participants will receive a combination of psychosocial and structural intervention, based on the most feasible selections from the preparation phase of the study.
The intervention will initiate in a referral-based fashion in which participants will receive referral at enrollment visit.
Participants will receive a combination of psychosocial and structural intervention, based on the most feasible selections from the preparation phase of the study.
The intervention will initiate in an integrated fashion in which participants will receive immediate onboard at enrollment visit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Burden
Time Frame: up to 12 weeks
|
An existing validated tool designed to assess research participant burden (Lingler et al., 2014) for cultural and contextual appropriateness; the tool includes 21 items assessed on a 5-point Likert agreement scale and the final adapted items will be summed for a total score.
Higher scores mean a worse outcome.
|
up to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cost effectiveness
Time Frame: 3 months
|
Cost factors were identified by the study team during the preparation phase and measured based on personnel time, commodities, and other relevant factors for the delivery of the intervention components.
Effects will then be computed based on the physical burden to determine the cost-effectiveness ratio.
|
3 months
|
|
session attendance
Time Frame: 3 months
|
Participant are expected to attend 12 intervention sessions over the course of 3 months.
Attendance will be recorded by the participant manager as a categorical variable (yes/no).
Higher attendance will mean a better outcome.
|
3 months
|
|
diet quality
Time Frame: up to 3 months
|
Dietary intake will be assessed using the NHANES Dietary Screener Questionnaire, which is a validated food frequency questionnaire assessing food intake over the past month.
Participants will be asked to complete this at baseline, month 1, month 2, and post program.
Increases in consumption of foods such as fruits, vegetables, whole grains, dairy/calcium and decreases in added sugars, red meat, and processed meat will mean a better outcome.
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: June Gipson, PhD, My Brother's Keeper, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2022
Primary Completion (Actual)
September 24, 2024
Study Completion (Actual)
September 24, 2024
Study Registration Dates
First Submitted
February 13, 2024
First Submitted That Met QC Criteria
February 21, 2024
First Posted (Actual)
February 29, 2024
Study Record Updates
Last Update Posted (Estimated)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HHSN268201800015I (Other Grant/Funding Number: NHLBI and NIMHD)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study is pilot in nature and is being used to support intervention development.
Due to the small sample size, the data would not be suitable for secondary analysis.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.